Orion Infusion Limited (DSE: ORIONINFU)

Market Cap	7.41B
Revenue (ttm)	790.20M
Net Income (ttm)	39.97M
Shares Out	20.36M
EPS (ttm)	1.96
PE Ratio	185.43
Forward PE	n/a
Dividend	1.20 (0.33%)
Ex-Dividend Date	Dec 5, 2024

Volume	177,303
Average Volume	301,644
Open	375.10
Previous Close	374.60
Day's Range	361.90 - 379.30
52-Week Range	217.20 - 726.90
Beta	-1.74
RSI	46.45
Earnings Date	Jan 29, 2025

About Orion Infusion

Orion Infusion Limited manufactures and sells large volume parenteral and other lifesaving injectable products in Bangladesh. The company offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; metronidazole I.V; pure steam generated fluids; and amino acids solution. The company was formerly known as Mala Chemical & Pharmaceuticals Industries Ltd. and changed its name to Orion Infusion Limited in 1994. Orion Infusion Limited was incorporated in 1983 and is based in Dhaka, Bangladesh.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1983
• Employees: 718
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ORIONINFU

Financial Performance

In 2024, Orion Infusion's revenue was 827.42 million, an increase of 2.13% compared to the previous year's 810.15 million. Earnings were 42.33 million, an increase of 1.03%.